Keep in mind: A viable vaccine does Not Yet Exist. The projected time-frame for when an effective one will be available ranges from the end of 2020 to the end of 2021. Current and projected numbers of cases, deaths, and vaccine availability have changed significantly since the White House has taken over direct control of CDC calculations, proceedings, and reports.
A new report, reviewed by health coaches in Rocklin CA, ranking which populations should be the first to receive the coronavirus vaccine was released on Tuesday by the National Academies of Sciences, Engineering and Medicine’s Committee on Equitable Allocation of Vaccine for the Novel Coronavirus.
The plan is based on the Centers for Disease Control’s Social Vulnerability Index, which is divided into Four Phases.
At the top of the list are front-line health care workers involved directly with COVID-19 patients including first responders. Vulnerable adults–irrespective of age–with “significant” underlying health conditions and the elderly living in nursing homes or other long-term care facilities should also be among the first to get vaccinated, according to the 114-page document.
Phase 2 includes “critical risk workers essential to the functioning of society,” teachers and school staff, the homeless, those who are incarcerated, detention center workers and individuals with “moderate” underlying health conditions.
Children, young adults and essential workers not included in Phase 2 constitute Phase 3. The remainder of the U.S. population rounds up the fourth and final phase.
Attention, to date, has been put toward developing a safe and effective coronavirus vaccine. But health officials have warned since the beginning of Operation Warp Speed (the “Law of the Harvest” suggests that Considerable Risk could be a factor here) that there will likely be a shortage of that vaccine, especially now that evidence is mounting two doses will most likely be necessary for immunity.
The rest of the world:
- A Chinese Doctor has claimed to have developed an oral vaccine that he tested on himself, with no apparent side-effects. No other information is available at this time.
- China and Russia are vaccinating on an ‘emergency need’ only with their early version
- Sub-Saharan Africa is apparently making good progress in their vaccine development
- The UK and Italy have both suffered ‘set-backs’ in their vaccine development
- Germany (my personal favorite, based on studying all of them) is progressing well through all of the traditional vaccine development steps and anticipates human testing to begin by the End of April 2021, and plans to share their successful formula with the entire world, by the end of 2021, or sooner, if all goes well.